Showing results (61-70 of 106) with videos related to
Sort By:
Pageof 11
Therapeutic Drug Monitoring|July 9, 2016
Kinetics of Linezolid in Continuous Renal Replacement Therapy: An In Vitro StudyMarco Sartori, Arianna Loregian, Silvana Pagni, et al.Antiviral Research|January 29, 2024
Human neural progenitor cell models to study the antiviral effects and neuroprotective potential of approved and investigational human cytomegalovirus inhibitorsMarta Trevisan, Anna Pianezzola, Marco Onorati, et al.Chemmedchem|May 23, 2026
Streamlined Synthesis and Structure-Activity Relationship Analysis of 2-Amidothiophene-3-Carboxamides Targeting Influenza Polymerase PA-PB1 HeterodimerizationTommaso Felicetti, Alessia Zago, Andrea Astolfi, et al.Chemmedchem|June 13, 2013
Design, synthesis, and evaluation of WC5 analogues as inhibitors of human cytomegalovirus Immediate-Early 2 protein, a promising target for anti-HCMV treatmentSerena Massari, Beatrice Mercorelli, Luca Sancineto, et al.European Journal of Medicinal Chemistry|September 17, 2021
Indomethacin-based PROTACs as pan-coronavirus antiviral agentsJenny Desantis, Beatrice Mercorelli, Marta Celegato, et al.Pharmaceutics|July 27, 2024
Exploring a New Generation of Pyrimidine and Pyridine Derivatives as Anti-Influenza Agents Targeting the Polymerase PA-PB1 Subunits InteractionIlaria Giacchello, Annarita Cianciusi, Chiara Bertagnin, et al.Antiviral Research|May 3, 2006
Antiviral properties of new arylsulfone derivatives with activity against human betaherpesvirusesLieve Naesens, Chad E Stephens, Graciela Andrei, et al.Acta Pharmaceutica Sinica. B|July 18, 2022
Contemporary medicinal chemistry strategies for the discovery and optimization of influenza inhibitors targeting vRNP constituent proteinsLingxin Hou, Ying Zhang, Han Ju, et al.Journal of Virology|October 10, 2008
Role of homodimerization of human cytomegalovirus DNA polymerase accessory protein UL44 in origin-dependent DNA replication in cellsElisa Sinigalia, Gualtiero Alvisi, Beatrice Mercorelli, et al.European Journal of Medicinal Chemistry|July 1, 2017
Exploring the cycloheptathiophene-3-carboxamide scaffold to disrupt the interactions of the influenza polymerase subunits and obtain potent anti-influenza activityJenny Desantis, Giulio Nannetti, Serena Massari, et al.Pageof 11